PreprintGenes Dev2021
The biological underpinnings of therapeutic resistance in pancreatic cancer.
- Journal
- Genes Dev
- Published
- 11 June 2021
- Citations
- 124
- Type
- Preprint
- License
- cc by-nc
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Early Detection Biomarkers in Pancreatic Adenocarcinoma R01CA131045↗
- Targeting the liver for immunotherapy in pancreatic cancer R01CA197916↗
- Regulation of Pancreatic Oncogenesis by the Gut Microbiome R01CA206105↗
- Targeting metabolic stress to induce pancreatic tumor cell death R01CA244931↗
- POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma R01CA245005↗
- Stromal metabolism promotes therapeutic resistance in pancreatic cancer R01CA248160↗
- Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer R37CA237421↗
- Stopping PDA progression using inhibitors of CSC dissemination and immunotherapy U01CA224193↗